Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Contacts
location
Contact Email
Website URL
Similar Companies491
NextGen Ventures
NextGen Ventures invests in digital health and medtech startups to improve healthcare.
Sector
Subsector
Location
count Of Investments
HealthX Ventures
HealthX Ventures is a digital healthcare-focused seed fund.
Sector
Subsector
Location
count Of Investments
count Of Exists
HealthXCapital
HealthXCapital is Asia's first healthtech venture capital fund, investing in innovative health tech solutions for South and Southeast Asia.
Sector
Subsector
Keywords
Location
count Of Investments
New Leaf Venture Partners
New Leaf Venture Partners is a venture capital firm that invests in healthcare technology companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Financials
Investments34
FEMSelect
FEMSelect is a medical device company that offers an innovative technology platform for women's health.
Sector
Subsector
Keywords
Location
total rounds
total raised
Future Family
Future Family is a subscription fertility company that offers easy plans for IVF and egg freezing with on-demand medical support.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
PayGround
PayGround simplifies healthcare bill-pay by unifying providers and patients on a single payment platform.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Exits6
Cardiva Medical
Cardiva Medical is a medical device company developing and commercializing innovative vascular closure technology.
Sector
Subsector
Location
total rounds
total raised
Apica Cardiovascular
Apica Cardiovascular is a developer of cardiovascular devices.
Sector
Subsector
Location
total rounds
total raised
OrthoSpace
OrthoSpace develops biodegradable balloon systems for the orthopaedic market.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders3
Martin Leon
Martin Leon is Professor of Medicine at Columbia University Medical Center (CUMC). Martin Leon is also Director of the Center for Interventional Vascular Therapy (CIVT), Director of the Cardiac Catheterization Laboratories, and on the Executive Board of the Columbia New York Presbyterian Heart Valve Center. He continues as a practicing Interventional cardiologist at New York-Presbyterian Hospital in New York City. Martin Leon is the Founder and Chairman Emeritus of the Cardiovascular Research Foundation. Martin Leon has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including the following studies: STRESS, STARS, Gamma-one, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial, studying the value of transcatheter valve therapy for patients with aortic stenosis. Martin Leon has co-authored over 1550 publications, has performed over 10,000 interventional procedures, and has had a major impact as a thought-leader and innovator in the expanding sub-specialty of interventional cardiovascular device and drug therapies. He is the Director and Founder of Transcatheter Cardiovascular Therapeutics (TCT), the world’s premier interventional cardiovascular meeting, which recently celebrated its 26th anniversary. Martin Leon has also served as Director or Co-Director of more than 100 international educational programs in areas of interventional cardiology. Martin Leon has received 10 international career achievement awards and was awarded an honorary degree from the University of Athens. Martin Leon was previously the Director of Cardiovascular Research and Education at the Lenox Hill Heart and Vascular Institute in New York. Prior to that, he was Director of Clinical Research at the Washington Cardiology Center at the Washington Hospital Center and Clinical Professor of Medicine at Georgetown University Medical Center in Washington, DC. Earlier in his career, he served as a Clinical Associate, Senior Investigator, and Director of the Catheterization Laboratories in the Cardiology Branch of the National Heart, Lung and Blood Institute at the National Institutes of Health in Bethesda, MD. He was a founder of the Washington Cardiology Center and the Cardiology Research Foundation in Washington, DC.
current job
Martin Leon
Peter Fitzgerald
Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Professor in both the Departments of Medicine and Engineering at Stanford. Presently, Peter Fitzgerald’s laboratory includes 17 postdoctoral fellows and graduate engineering students focusing on state-of-the-art technologies in Cardiovascular Medicine. He has led or participated in over 150 clinical trials, published over 450 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade. In addition, he heads the Stanford/Asia MedTech innovation program Peter has been principle/founder of eighteen medical device companies in the San Francisco Bay Area. He has transitioned twelve of these start-ups to large medical device companies.
current job
Peter Fitzgerald
Michal Geva
Michal Geva has over 15 years of extensive hands-on experience in Israeli and American medical device companies. She has held executive roles in regulatory & clinical affairs, and/or quality assurance and marketing at ByPass, a developer of a cardiovascular anastomotic device (collaborated with J&J), AST, a developer of a stent and stent delivery system (acquired by Boston Scientific for $120 million), and GI View, a developer of advanced endoscope technologies for the GI tract, among others. Michal has been an advisor to several American companies and funds with activities in Israel. Michal is a Co-Founder and a Managing Partner of TriVentures.
current job
Michal Geva